COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,388 Articles (22,816 medRxiv, 8,572 bioRxiv)

Most recent first Previous |  Page 1320: Articles 13191-13200  | Next

Geospatial Variability in Excess Death Rates during the COVID-19 Pandemic in Mexico: Examining Socio Demographic and Population Health Characteristics
Dahal, S., Luo, R., Swahn, M. H., Chowell, G.
10.1101/2021.08.11.21261930 — Posted: 2021-08-12
Specificity of SARS-CoV-2 antibody-detection assays against S and N protein among pre-COVID-19 sera from patients with protozoan and helminth parasitic infections
Yansouni, C. P., Papenburg, J., Cheng, M. P., Corsini, R., Caya, C., Vasquez Camargo, F., Harrison, L. B., Zaharatos, G., Buscher, P., Faye, B., Ndiaye, M., Matlashewski, G., Ndao, M.
10.1101/2021.08.10.21261841 — Posted: 2021-08-12
Clinical features, demography and predictors of outcomes of SARS-CoV-2 infection in a tertiary care hospital in India-A cohort study
Elavarasi, A., Sagiraju, H. K. R., Garg, R. K., Ratre, B., Sirohiya, P., Gupta, N., Garg, R., Pandit, A., Vig, S., Nalwa, R., Kumar, B., Meena, V. P., Wig, N., Mittal, S., Pahuja, S., Madan, K., Guleria, R., Mohan, A., Dwivedi, T., Gupta, R., Vidyarthi, A. J., Wundavalli, L., Singh, A. R., Singh, S., Kumar, S., Bhatnagar, S.
10.1101/2021.08.10.21261855 — Posted: 2021-08-12
Data analysis of COVID-19 wave peaks in relation to latitude and temperature for multiple nations
Jain, M., Aloni, S., Adivarekar, P.
10.1101/2021.08.12.21261974 — Posted: 2021-08-12
A highly efficient T-cell immunoassay provides assessment of B cell help function of SARS-CoV-2 specific memory CD4+ T cells
Ansari, A., Sachan, S., Jit, B. P., Sharma, A., Coshic, P., Sette, A., Weiskopf, D., Gupta, N.
10.1101/2021.08.12.21261970 — Posted: 2021-08-12
Neutralization of VOCs including Delta one year post COVID-19 or vaccine
Havervall, S., Marking, U., Gordon, M., Ng, H., Greilert-Norin, N., Lindbo, S., Blom, K., Nilsson, P., Phillipson, M., Klingstrom, J., Mangsbo, S., Aberg, M., Hober, S., Thalin, C.
10.1101/2021.08.12.21261951 — Posted: 2021-08-12
Saliva molecular testing bypassing RNA extraction is suitable for monitoring and diagnosing SARS-CoV-2 infection in children
Alenquer, M., Milheiro Silva, T., Akpogheneta, O., Ferreira, F., Vale-Costa, S., Medina-Lopes, M., Batista, F., Garcia, A. M., Barreto, V. M., Paulino, C., Costa, J., Sobral, J., Diniz-da-Costa, M., Ladeiro, S., Delgado Alves, J., Leite, R. B., Demengeot, J., Rocha Brito, M. J., Amorim, M. J.
10.1101/2021.08.11.21261899 — Posted: 2021-08-12
Durability of SARS-CoV-2-specific T cell responses at 12-months post-infection
Lu, Z., Laing, E. D., Pena-Damata, J., Pohida, K., Tso, M. S., Samuels, E. C., Epsi, N. J., Dorjbal, B., Lake, C., Richard, S. A., Maves, R. C., Lindholm, D. A., Rozman, J., English, C., Huprikar, N., Mende, K., Colombo, R. E., Colombo, C. J., Broder, C. C., Ganesan, A., Lanteri, C. A., Agan, B. K., Tribble, D., Simons, M. P., Dalgard, C. L., Blair, P. W., Chenoweth, J., Pollett, S. D., Snow, A. L., Burgess, T. H., Malloy, A. M.
10.1101/2021.08.11.455984 — Posted: 2021-08-11
Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: a pan India study
Kumar, S., Bansal, K.
10.1101/2021.08.11.455899 — Posted: 2021-08-11
SARS-CoV-2 Spike S1 glycoprotein is a TLR4 agonist, upregulates ACE2 expression and induces pro-inflammatory M1 macrophage polarisation.
Aboudounya, M. M., Holt, M. R., Heads, R. J.
10.1101/2021.08.11.455921 — Posted: 2021-08-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).